Active ingredientOzagrelCat. No. P-O082-001CAS 82571-53-7Family · Pharmaceutical analytical standards
Ozagrel
A thromboxane A2 synthase inhibitor used in Japan since at least the 1990s, to prevent spasm of the cerebral arteries after subarachnoid haemorrhage and, as the hydrochloride, for asthma. This family brings together the active ingredient and other impurities.
Did you know?It reduces the production of thromboxane A2, the substance platelets release to clump together and narrow blood vessels: this is why it is classed among the antiplatelet agents.
Go to the active ingredient →Active ingredientOzagrelCat. No. P-O082-001CAS 82571-53-7
Active ingredientOzagrel HClCat. No. P-O082-002CAS 78712-43-3
Impurity4-(Hydroxymethyl)cinnamic acidCat. No. P-O082-003CAS 1332370-00-9
Impurity4-MethylbenzaldehydeCat. No. P-O082-004CAS 104-87-0
Impurity67688-89-5(HCl salt)Cat. No. P-O082-005CAS 67688-89-5
Impuritycis-OzagrelCat. No. P-O082-006CAS 143945-86-2
ImpurityOzagrel Impurity 1Cat. No. P-O082-007CAS 530145-11-0
ImpurityOzagrel Impurity 2Cat. No. P-O082-008CAS 78712-80-8
ImpurityOzagrel Impurity 3Cat. No. P-O082-009CAS 20754-20-5
ImpurityOzagrel Impurity 4Cat. No. P-O082-010CAS 130451-86-4
ImpurityMethyl (E)-3-(m-tolyl)acrylateCat. No. P-O082-011CAS 95416-56-1
ImpurityOzagrel Impurity 5 (Bromide salt)Cat. No. P-O082-013
ImpurityOzagrel Impurity 6Cat. No. P-O082-014
ImpurityOzagrel Methyl EsterCat. No. P-O082-015CAS 866157-50-8
Impurityp-Formylcinnamic acidCat. No. P-O082-016CAS 23359-08-2
ImpurityOzagrel Impurity 7Cat. No. P-O082-017CAS 731846-61-0No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.